BOTH METABOTROPIC AND IONOTROPIC GLUTAMATE RECEPTORS PRESENT ATTRACTIVE “DRUGGABLE” TARGETS IN TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM. THERE HAS BEEN A DRAMATIC SHIFT IN THE FOCUS OF GLUTAMATE-BASED THERAPIES AWAY FROM NEUROLOGIC DISORDERS SUCH AS STROKE AND TRAUMATIC BRAIN INJURY TO THE TREATMENT OF PSYCHIATRIC DISORDERS. THIS “MILESTONES IN DRUG THERAPY” VOLUME OFFERS A UNIQUE, CONTEMPORARY OVERVIEW OF PRECLINICAL AND CLINICAL EVIDENCE THAT MODULATING GLUTAMATERGIC TONE IS AN EFFECTIVE MEANS OF TREATING PSYCHIATRIC DISORDERS RANGING FROM DEPRESSION AND ANXIETY TO SCHIZOPHRENIA AND DRUG ABUSE. THE ABILITY TO TREAT DISEASES SUCH AS DEPRESSION AND SCHIZOPHRENIA THROUGH MULTIPLE, GLUTAMATE-BASED MECHANISMS OFFERS A UNIQUE THERAPEUTIC OPPORTUNITY, AS DESCRIBED IN THIS BOOK.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
From the reviews:
“This book summarizes the translational research in the development of glutamate-based approaches to treat psychiatric disorders. Written and edited by an international group of researchers, it is an important addition to the psychiatric literature. ... The intended audience includes psychiatric researchers and psychiatrists. Neuroscientists interested in the treatment of patients with psychiatric disorders also would benefit from reading this book. ... The index is quite helpful. ... presents a unique and novel approach that is desperately needed in the treatment of these difficult disorders.” (Michael Joel Schrift, Doody’s Review Service, February, 2011)Both metabotropic and ionotropic glutamate receptors present attractive "druggable" targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This "Milestones in Drug Therapy" volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Versand:
EUR 45,00
Von Deutschland nach USA
Versand:
EUR 2,36
Innerhalb der USA
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New. Bestandsnummer des Verkäufers 11627461-n
Anzahl: 1 verfügbar
Anbieter: booksXpress, Bayonne, NJ, USA
Hardcover. Zustand: new. Bestandsnummer des Verkäufers 9783034602402
Anzahl: 10 verfügbar
Anbieter: Buchpark, Trebbin, Deutschland
Zustand: Sehr gut. Zustand: Sehr gut - Neubindung, Buchschnitt leicht verkürzt, Buchecken leicht angestoßen | Seiten: 192 | Sprache: Englisch | Produktart: Bücher. Bestandsnummer des Verkäufers 7919458/12
Anzahl: 1 verfügbar
Anbieter: Lucky's Textbooks, Dallas, TX, USA
Zustand: New. Bestandsnummer des Verkäufers ABLIING23Mar3113020037570
Anzahl: Mehr als 20 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Bestandsnummer des Verkäufers ria9783034602402_lsuk
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPricesUK, Castle Donington, DERBY, Vereinigtes Königreich
Zustand: New. Bestandsnummer des Verkäufers 11627461-n
Anzahl: 1 verfügbar
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Both metabotropic and ionotropic glutamate receptors present attractive 'druggable' targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This 'Milestones in Drug Therapy' volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book. 192 pp. Englisch. Bestandsnummer des Verkäufers 9783034602402
Anzahl: 2 verfügbar
Anbieter: moluna, Greven, Deutschland
Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Contemporary monograph on glutamate-based approaches to treat psychiatric drugs The approaches described in this text exploit both metabotropic and ionotropic glutamate receptors Focus on translational research, with many of the authors coming from industr. Bestandsnummer des Verkäufers 4317895
Anzahl: Mehr als 20 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Both metabotropic and ionotropic glutamate receptors present attractive 'druggable' targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This 'Milestones in Drug Therapy' volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book. Bestandsnummer des Verkäufers 9783034602402
Anzahl: 1 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Hardcover. Zustand: Brand New. 1st edition. 178 pages. 10.00x6.50x0.75 inches. In Stock. Bestandsnummer des Verkäufers x-3034602405
Anzahl: 2 verfügbar